Results showed that DR4/DR5 and DcR1/DcR2 were significantly more abundant on cancer cells than those on normal cells, and levels of DR4 and DR5 were higher than those of DcR1/2 (Figure 3A). This evidence concerns the gene TNFRSF10A and cancer.